ArticleLeukemia research reports2018

Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL.

Muhammad Bilal Abid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.